-
[Illinois] BioNanotechnology and Nanomedicine: Applications in Cancer and Mechanobiology Lecture 26: A few basics of mechanics in light of cell biology
Online Presentations | 12 Jun 2013 | Contributor(s):: Taher A. Saif
BioNanotechnology and Nanomedicine: Applications in Cancer and Mechanobiology provides an introduction to basic concepts of nanotechnology in mechanobiology and in cancer. This is a highly interdisciplinary field of research where knowledge from various disciplines is presented and integrated....
-
[Illinois] BioNanotechnology and Nanomedicine: Applications in Cancer and Mechanobiology Lecture 27: Cancer Metastasis and Elasticity of Micro-Environment
Online Presentations | 12 Jun 2013 | Contributor(s):: Taher A. Saif
BioNanotechnology and Nanomedicine: Applications in Cancer and Mechanobiology provides an introduction to basic concepts of nanotechnology in mechanobiology and in cancer. This is a highly interdisciplinary field of research where knowledge from various disciplines is presented and integrated....
-
[Illinois] CMMB IGERT and M-CNTC Annual Symposium 2013
Workshops | 06 Jun 2013
The CMMB IGERT is training the next generation of leaders who will define the new frontiers of cellular and molecular mechanics and bionanotechnology. Integrating biology and medicine with micro and nanotechnology can be categorized into two broad areas, namely how micro/nano-fabrication can help...
-
[Illinois] CMMB IGERT & M-CNTC Annual Symposium: Program Overview
Online Presentations | 06 Jun 2013 | Contributor(s):: Taher A. Saif
The second annual CMMB IGERT PI and Trainee Meeting was held on August 31, 2011. Dr. Saif walks through the goals and current status of the programs, and introduces the students involved.
-
[Illinois] CNST 2012: Nanotechnology-mediated Sensing of Angiogenesis
Online Presentations | 02 Jun 2013 | Contributor(s):: Princess I. Imoukhuede
…
-
[Illinois] Cancer Community Symposium 2012
Workshops | 16 May 2013
Cancer Community At Illinois Symposium 2012 April 5-6, 2012: Connecting patient care, research, and scientific advancementSymposium PremiseThis on-campus research symposium aims to bring together members of campus and the surrounding community to foster interdisciplinary discussions on cancer...
-
[Illinois] Bionanotechnology Seminar Series Fall 2012: Mechanical Property Characterization for 3D Collagen Cancer Cell Cultures
Online Presentations | 08 Mar 2013 | Contributor(s):: Yue Wang
The tumor microenvironment is mechanically modified during cancer progression. Imaging of tumor mechanical environment will provide new information for early cancer diagnosis. However, it is less clear how the mechanical environment is tuned in cancer. The goal of this study is to understand more...
-
[Illinois] B3SI 2012: Circumventing Barriers to Nanoparticle Delivery In Vivo
Online Presentations | 02 Aug 2012 | Contributor(s):: Susan E. Clare
…
-
[Illinois] Biophotonics 2012: Chemical Imaging for Cancer Pathology
Online Presentations | 05 Jun 2012 | Contributor(s):: Michael Walsh
…
-
[Illinois] Biophotonics 2012: Breast Cancer Biomarkers - From Serendipity to Rational Discovery
Online Presentations | 25 May 2012 | Contributor(s):: Partha Ray
…
-
[Illinois] Cancer Community Symposium 2012: T Cell Receptors For Potential Cancer Immunotherapy Applications: Single Chain T Cell Receptors Circumvent Mispairing with Endogenous TCR and Mediate T Cell Activity
Online Presentations | 09 May 2012 | Contributor(s):: David H. Aggen
To improve the immune response to cancer, gene therapy with tumor-specific T cell-receptors (TCRs) provides an attractive approach to effectively arm patients T cells for tumor cell destruction. A high-affinity TCR specific for an antigenic peptide-major histocompatibility complex (pepMHC) can be...
-
[Illinois] Cancer Community Symposium 2012: Imaging Estrogen Receptors and Estrogen-Receptor Function in Breast Cancer by Positron Emission Tomography (PET): Improved Selection of Patients for Benefit from Endocrine Therapies
Online Presentations | 09 May 2012 | Contributor(s):: John A. Katzenellenbogen
The growth of many breast cancers is regulated by estrogens, and these cancers can be treated effectively with endocrine therapies (ET). Identifying patients who will benefit from ET, however, continues to be challenging. Measurement of estrogen receptor (ER) levels in tumor biopsy samples using...
-
[Illinois] Cancer Community Symposium 2012: The Man with the Crateriform Lesion: Advanced Squamous Cell Carcinoma
Online Presentations | 09 May 2012 | Contributor(s):: Joseph Brancheck
Cutaneous squamous cell carcinoma (SCC) is the second most common type of skin cancer in the United States and accounts for 20 percent of non-melanoma skin cancers; in addition, it is the second most common cancer overall in Caucasians. Due to an aging population and increasing sun exposure, the...
-
[Illinois] Cancer Community Symposium 2012: Speaking Up: The Patient Push for Accelerating Progress in Cancer Research
Online Presentations | 09 May 2012 | Contributor(s):: Leslie Hammersmith
Medical research empowers us to fight cancer, and advocacy empowers us to ensure that it addresses the needs of people affected by cancer. Advocacy helps us get through our cancer experiences, stand up for all people affected by cancer and gain a feeling of control over our own healthcare. Young...
-
[Illinois] Cancer Community Symposium 2012: Materials Science vs. Metastasis
Online Presentations | 09 May 2012 | Contributor(s):: Daniel A. Heller
Metastasis, the spread of cancer cells from a primary tumor to seed secondary tumors in distant sites, is one of the greatest challenges in cancer treatment today. For many patients, by the time cancer is detected, metastasis has already occurred. Over 80% of patients diagnosed with lung cancer,...
-
[Illinois] Cancer Community Symposium 2012: Chemical Imaging for Histopathology: An Emerging Route for Molecular and Structural Analysis of Tissues
Online Presentations | 09 May 2012 | Contributor(s):: Michael Walsh
Mid-Infrared (IR) spectroscopic imaging is an emerging approach to derive chemical images from tissues based on their inherent biochemistry. Histologic diagnosis is the gold standard for evaluating the presence and severity of most diseases. Current histopathological techniques use of panel of...
-
[Illinois] Cancer Community Symposium 2012: Panel Discussion
Online Presentations | 09 May 2012
Please join us for a panel discussion on the social impact of cancer and how it affects patients, providers, clinicians, and researchers alike. We are fortunate to feature Leslie Hammersmith (moderator), Jennifer Smith, and Patience Anders from the local Young Survival Coalition, as well as an...
-
[Illinois] Cancer Community Symposium 2012: Understanding and Targeting Transcription in Hematological Malignancies
Online Presentations | 09 May 2012 | Contributor(s):: Jonathan D. Licht
Abnormalities in the epigenetic regulation of chromatin structure and function can lead to aberrant gene expression and cancer development. Epigenetic regulators can be affected by chromosomal rearrangement, point mutations, deletions and amplifications in cancer. The result may be changes in the...
-
[Illinois] Cancer Community Symposium 2012: The Inhibitory Effects of the Antifibrotic Drug Halofuginone on Uterine Leiomyoma Smooth Muscle Cells
Online Presentations | 09 May 2012 | Contributor(s):: Faezeh Koohestani
Uterine leiomyomas are the most prevalent benign tumors of the reproductive tract in women. Available treatments for leiomyomas are limited to surgical procedures or hormonal therapy, which are costly and have significant side effects. In an effort to develop alternative therapeutic strategies,...
-
[Illinois] Cancer Community Symposium 2012: Arginine Glycine Aspartic Acid Motif Peptide Potentiates the Effect of Oxaliplatin Preventing Colon Cancer Metastasis, Binds to α5 β1 Integrin and Suppresses FAK/ERK/NF-kB Signaling
Online Presentations | 09 May 2012 | Contributor(s):: Elvira de Mejia
Arginine Glycine Aspartic Acid Motif Peptide Potentiates the Effect of Oxaliplatin Preventing Colon Cancer Metastasis, Binds to α5 β1 Integrin and Suppresses FAK/ERK/NF-kB SignalingLunasin is a promising chemopreventive agent. The objective was to study the effect of lunasin on human colon cancer...